◂ Announcements

Medical Devicesworld trade 2024+5.1% 5Y CAGR

Nov 1, 2022ACQUISITION

Johnson & Johnson to acquire Abiomed in $16.6B deal

Johnson & Johnson agreed to acquire heart-support device maker Abiomed through a tender offer at $380 per share in cash plus a contingent value right of up to $35 per share, an enterprise value of about $16.6 billion.

Value

$16.6B

Status

Announced

Productsheart recovery and support devices

CompaniesJohnson & Johnson acquirer Abiomed target

Sectors#Medical Devices

“Johnson & Johnson will acquire through a tender offer all outstanding shares of Abiomed, for an upfront payment of $380.00 per share in cash, corresponding to an enterprise value of approximately $16.6 billion”jnj.com

1 source
jnj.comJohnson & Johnson to Acquire AbiomedNov 1, 2022

Summarized from public sources; check the original articles before acting on it.

Similar announcements

Oct 1, 2026ACQUISITION
SteelcoBelimed acquires NCG Sensor technology from SolidToo
SteelcoBelimed acquirer SolidToo target steelcobelimed.com
Dec 8, 2025ACQUISITION
Nelipak completes acquisition of Merrill's Packaging
Nelipak Corporation acquirer Merrill's Packaging target packagingstrategies.com
Nov 5, 2026ACQUISITIONUnited States$538.0M
ZOLL Medical to acquire Itamar Medical for $538M
Asahi Kasei investor ZOLL Medical Corporation acquirer forpressrelease.com
Nov 4, 2026ACQUISITIONPlano, Texas, United States$2.25M
OSTEONIC acquires controlling stake in FoxEyes for 3 billion won
OSTEONIC FoxEyes target en.edaily.co.kr
Nov 3, 2026ACQUISITIONDeerfield, Illinois, United States
Vantive to divest majority of hemodialysis assets to Rockwell Medical
Vantive Rockwell Medical acquirer prnewswire.com
Nov 3, 2026ACQUISITIONMedolla, Italy, Italy
Rockwell Medical to acquire Vantive's hemodialysis business for $400-450M annual revenue
Rockwell Medical acquirer Vantive target sec.gov nasdaq.com businesswire.com

Loading…